MCK241108C570000
- 43.68
- 0.000.00%
McKesson Newsroom
Argus Adjusts Price Target on McKesson to $660 From $570
Tuesday Market Finally Slows Down, Takes a Post Veterans Day Breather | Live Stock
Ontada Collaborates With Datavant to Enable Faster Access to Market-Leading Oncology Insights
McKesson Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Market Opens to Fresh Highs | Live Stock
McKesson, Oracle Among Finalists Looking to Buy Veradigm, Axios Reports
Here's Why McKesson (MCK) Is a Strong Momentum Stock
Barclays Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $668
Investors Elect to Accelerate Market on Election Week | Weekly Buzz
Friday Market Finished with Records | Wall Street Today
TSLA Up, China Down, Friday Market Quiet After Loud, Decisive Week | Live Stock
Express News | Mckesson Corp : UBS Raises Target Price to $708 From $590
McKesson Price Target Raised to $651 From $642 at TD Cowen
Evercore Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $680
Today's Analyst Rating | Citi Upgrades Bank of America to Buy, Arm Holdings Price Target Raised to $145 by Barclays
A Quick Look at Today's Ratings for McKesson(MCK.US), With a Forecast Between $612 to $688
Analysts Offer Insights on Healthcare Companies: Aclaris Therapeutics (ACRS), McKesson (MCK) and Enhabit, Inc (EHAB)
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
FOMC Cut Sends Prices Up, Election Blitz Strong | Wall Street Today
McKesson | 10-Q: Q2 2025 Earnings Report